Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Evaxion Biotech A/S Sponsored ADR (EVAX) Tangible Shareholders Equity data is not available for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-5.68M |
|
-- |
|
-- |
|
$5.76M |
|
$-5.76M |
|
$-0.11M |
|
$-5.87M |
|
$-5.87M |
|
$-5.68M |
|
$-5.68M |
|
$-5.68M |
|
$-5.68M |
|
$-5.76M |
|
-- |
|
2.77M |
|
2.77M |
|
$-2.10 |
|
$-2.10 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Tangible Shareholders Equity |
-- |
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|